90 results
Page 3 of 5
8-K
EX-99.1
doi00 ij7
28 Apr 21
Regulation FD Disclosure
1:31pm
8-K
EX-99.1
3kzk a6ku2kkc8l
27 Apr 21
Regulation FD Disclosure
4:22pm
8-K
EX-99.2
2jkj1
27 Apr 21
Regulation FD Disclosure
4:22pm
424B3
2svie9g3
16 Mar 21
Prospectus supplement
12:00am
S-8
EX-5.1
8iqeufb
5 Mar 21
Registration of securities for employees
12:54pm
8-K
EX-99.1
863l4wp05
4 Mar 21
InMed to Present at Virtual Conferences in March 2021
3:21pm
8-K
EX-99.1
lhyl0ajb5g
16 Feb 21
InMed Announces Closing of US$4.5 Million Private Placement
6:12am
8-K
EX-99.1
ii3 fdaqz6tdwk6i
12 Feb 21
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results
12:35pm
8-K
EX-10.2
j0uf4 a2jw
5 Feb 21
InMed Announces US$4.5 Million Private Placement
5:28pm
8-K
EX-99.1
kr2cfuv0pl6j9dl1w
5 Feb 21
InMed Announces US$4.5 Million Private Placement
5:28pm
8-K
EX-99.1
y5rk5gw
20 Jan 21
Regulation FD Disclosure
3:43pm
8-K
EX-99.1
9mi12 kvkbjmln8da4nc
19 Jan 21
Regulation FD Disclosure
2:42pm
8-K
EX-99.1
5rlaggk9y9l5ng6k25
8 Jan 21
InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
10:53am
8-K
EX-99.1
tjp04wruxehddfnf
6 Jan 21
InMed to Participate at Virtual Conferences in January 2021
12:00am
8-K
EX-99.1
v77ywe2b
3 Dec 20
Regulation FD Disclosure
12:59pm
8-K
EX-99.1
kq0ibrf8mw45zphz
25 Nov 20
InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755
10:47am
8-K
EX-99.1
6wv2ztp
25 Nov 20
InMed Announces Election of Directors
12:00am
8-K
EX-99.1
tpdzl
18 Nov 20
Regulation FD Disclosure
12:31pm